NBSE - NeuBase Therapeutics to undertake 1-for-20 reverse share split
2023-06-14 09:03:15 ET
-
NeuBase Therapeutics said Wednesday that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20 to regain compliance with Nasdaq's listing rule.
-
The stock split will be effective as of 5:00 p.m. ET on June 14, 2023.
-
The reverse stock split will not change the authorized number of shares of the company’s common stock.
-
The reverse stock split will reduce the number of issued and outstanding shares of the company to about 1.7 million from 33.8 million.
-
Shares -16.6% at 15 cents premarket.
For further details see:
NeuBase Therapeutics to undertake 1-for-20 reverse share split